ESCMID Global 2026: real-world evidence of nirsevimab resistance

RSV susceptibility was compared in the POLYRES-2 project between infants who had received nirsevimab and those who were ...
Business Wire

Atropos Health Creates World’s Largest Body of Medical Evidence, Alexandria, for Clinical Decision Support and LLM Training to Improve Patient, Life Science, and Me…

Atropos Health, the world’s largest creator of real-world evidence (RWE) for clinical decision making, today announced the ...
JD Supra

FDA Finalizes Real-world Evidence Guidance for Device Sponsors, May Consider More RWE in Product Reviews

On December 17, the U.S. Food and Drug Administration (FDA) finalized its long-awaited guidance on the “Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices,” ...
The Manila Times

Truveta unveils Truveta Intelligence, delivering real-time insights from real-world data

New AI-powered experience removes the time-to-evidence barrier, enabling healthcare leaders to better understand and make ...
STAT

How real-world evidence is empowering treatment decisions in prostate cancer

Angela Jia, MD, PhD, is a radiation oncologist specializing in stereotactic body radiation therapy (SBRT), adaptive radiotherapy, and clinical trials focused on prostate, bladder, and kidney cancers.
The American Journal of Managed Care

Defining Future Needs for Real-World Evidence in mCRC

Panelists discuss how future RWE should expand to include survival, quality of life, and safety data to improve third-line mCRC care. Panelists identify gaps in current evidence and the need for more ...
The American Journal of Managed Care

Real-World Evidence in mCRC: Special Populations and Safety Assessment

Panelists discuss how RWE informs treatment and safety decisions for special populations such as patients with ECOG PS 2 with metastatic colorectal cancer. Panelists note that patients with ECOG ...
Forbes

From Real-World Evidence To Digital Quality: Why Life Sciences Needs Integrated Solutions

The life sciences industry is at a turning point. The pressures are mounting—shorten development timelines, meet regulatory demands and deliver therapies that patients actually need in the real world.
Morningstar

AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting

NORTH CHICAGO, Ill., March 27, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new research across its dermatology portfolio to be presented at the 2026 American Academy of Dermatology (AAD) ...
Morningstar

New Real-World Evidence Study Shows Leva® Pelvic Health System Significantly Improves Fecal Incontinence Symptoms in Women

Axena Health, Inc., a women's health company redefining the standard of care for pelvic health through clinically proven, non-invasive treatments, today announced the publication of a new real-world ...
RAPS

Califf: Leveraging Real World Evidence is 'Top Programmatic Priority' for FDA

The "top programmatic priority" for the US Food and Drug Administration (FDA), under Commissioner Robert Califf, is to leverage real world evidence from the healthcare system to inform FDA decision ...
Seeking Alpha

AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm’s Zio LTCM Clinical Superiority

In the largest real-world study of its kind with 428,707 patients, the Zio LTCM service outperformed other studied monitoring approaches in cardiac arrhythmia diagnostic yield, time to diagnosis, ...